TP53 and cancer: We determined that seven of 10 cancer types with p53LOF had reduced expression of a significantly (FDR < 0.05; Wilcoxon rank-sum test) higher percentage of p53-regulated lncRNAs compared with the percentage of background lncRNAs (Fig. 3D); a similar trend was observed in an eighth cancer type (Supplementary Fig. S2).